Matthew H. Kulke, MD; James C. Yao, MD; and Jonathan R. Strosberg, MD, explain the various treatment options available and their approaches to sequencing in the management of pancreatic neuroendocrine tumors.

This video is Part 1 of Pancreatic Neuroendocrine Tumors lecture (pNETs) and the symptoms that pNETs produces. The neuroendocrine pancreatic cancer is often mistaken for the pancreatic ductal adenocarcinoma. It is important to underline its biology because the treatment is radically different for the two conditions.
Pancreatic neruoendocrine review highlights rare neoplasms that are a distinct from the more common ductal pancreatic adenocarcinoma,. These is because of their variant behaviour, propensity to secrete chemicals and genetic component. This pancreatic neuroendocrine tutorial focuses on the essential basic understanding and how these tumors may produce symptoms.

00:00 Introduction
00:37 Basic understanding
02:30 Symptoms of neuroendocrine tumors
04:56 What are neuroendocrine tumors different?
05:49 Measuring malignant potential
07:04 Staging of pancreatic neuroendocrine tumors
The content of this channel is only for information purposes. This channel does not provide individual patient advice around diagnosis, investigations, or treatment. This is the sole responsibility of patients and their healthcare team/s.

The channel reserves the right to discuss specific medical conditions, independent of any assertions of applicability to individual patients.

James C. Yao, MD; Matthew H. Kulke, MD; and Jonathan R. Strosberg, MD, describe several indicators that help guide prognosis in patients with pancreatic neuroendocrine tumors.